Procter & Gamble Fiscal Q1 Core EPS of $2.00 Rises 1% as Net Sales Grow 4% to $23.3 Billion

The Procter & Gamble Company reported first-quarter fiscal 2027 results on Thursday, Oct. 22, for the quarter ended Sept. 30, 2026, with core earnings per share of $2.00, up 1% year over year, diluted earnings per share of $1.97, also up 1%, and net sales up 4% to $23.276 billion.

This is a fiscal first quarter, not a calendar third quarter: the period is the July to September quarter that opens Procter & Gamble's fiscal 2027, and the dating matters because the comparisons are against the same fiscal quarter a year earlier. The two earnings figures also need to stay separate. Core earnings per share of $2.00 is the company's non-GAAP measure, diluted earnings per share after items the company excludes, principally incremental restructuring charges of $0.03 per share this quarter; the GAAP figure is diluted earnings per share of $1.97. Currency-neutral core earnings per share were unchanged versus the prior year, so the reported 1% core gain was entirely a currency effect on the company's own arithmetic. Net sales were $23.276 billion, against $22.386 billion a year earlier. Organic sales, which exclude the impacts of foreign exchange and acquisitions and divestitures, also rose 4%.

Volume and mix did the work; pricing barely moved

The sales bridge was a volume story. Total volume rose 2.4%, favorable mix added 1.1%, pricing added 0.4% and foreign exchange was flat, which is why reported and organic growth landed at the same 4%. Profitability moved the other way: reported gross margin fell 160 basis points versus the prior year and core gross margin fell 150 basis points, as 140 basis points of higher commodity costs and 140 basis points of product reinvestments overwhelmed 120 basis points of gross productivity savings, a 50-basis-point tariff benefit from lower costs and recognized recoveries, and 20 basis points of higher pricing. Selling, general and administrative expense fell 90 basis points as a share of sales on a reported basis. Operating income was $5.937 billion, up 1%, and reported operating margin narrowed 70 basis points.

Fabric and Home Care remained the largest business

Fabric & Home Care net sales were $8.205 billion, up 4%, with organic sales up 5% and segment net earnings of $1.601 billion, up 3%. Beauty net sales were $4.410 billion, up 6%, with organic sales up 5% and segment net earnings of $868 million, down 1%, as hair care, personal care and skin care each grew organically in the mid-single digits. Baby, Feminine & Family Care net sales were $5.322 billion, up 3%, with organic sales up 3% and segment net earnings of $1.060 billion, down 4%. Health Care net sales were $3.318 billion, up 3%, with organic sales up 3% and segment net earnings of $783 million, up 9%, the fastest earnings growth of any segment. Grooming net sales were $1.889 billion, up 4%, with organic sales up 5% and segment net earnings of $477 million, up 3%. The pattern is a split print: the two care businesses closest to household staples carried sales, while Health Care carried profit growth and Baby, Feminine & Family Care was the only segment where earnings fell.

Cash return stayed heavy even as earnings were flat

Operating cash flow was $5.767 billion and net earnings were $4.757 billion, down 1% versus the prior year. Free cash flow was $4.401 billion, and free cash flow productivity was 93%: the company defines that measure as operating cash flow less capital spending, expressed as a percentage of net earnings, so it is a conversion ratio, not a cash figure. The company returned $3.9 billion of cash to shareowners in the quarter, via $2.6 billion of dividend payments and $1.3 billion of share repurchases. Chairman, President and Chief Executive Shailesh Jejurikar said the solid sales, earnings and cash results reflected sharpened execution of the company's integrated strategy, and that the start kept the company on track to deliver within its guidance ranges for organic sales growth, core earnings per share growth and free cash flow productivity for the fiscal year.

Guidance: the sales range was lifted for Thorne, the rest was held

The one guidance change was to the top line. The company updated its fiscal 2027 all-in sales growth range to 2% to 4% versus the prior year, reflecting the acquisition of Thorne as of Oct. 1, 2026, and maintained its outlook for organic sales growth of 1% to 3%, a range that already includes a headwind of 30 to 50 basis points from brand, product form and go-to-market discontinuations. Diluted earnings per share growth guidance was maintained at 1% to 5% versus fiscal 2026 diluted earnings per share of $6.62, and core earnings per share growth guidance was maintained at in-line to 3% versus fiscal 2026 core earnings per share of $6.89, which the company said equates to a range of $6.89 to $7.11 per share with a mid-point estimate of $7.00. The company now expects a commodity cost headwind of approximately $1.4 billion after tax, plus $300 million after tax from higher net interest expense, $150 million after tax from lower non-operating income and $50 million after tax from unfavorable foreign exchange, a combined headwind of $0.79 per share, or an 11% drag on core earnings per share growth. The core effective tax rate is now expected at 20% to 21%, capital spending at 4.5% to 5.5% of net sales, and free cash flow productivity at 85% to 90%, with dividends of over $10 billion and share repurchases of approximately $5 billion expected for the year - all company expectations, not results. What to watch next is whether volume can keep carrying growth if pricing stays near flat, whether commodity costs ease enough to stop the gross-margin slide, and how much of the lifted all-in sales range proves to be Thorne rather than the base business.